Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 43Recruiting 24Terminated 11Unknown 8Active not recruiting 4Not yet recruiting 3Available 3Withdrawn 2Suspended 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 16Gynecologic 2Genitourinary 2Breast 2Thoracic 1Sarcoma 1Head & Neck 1CNS 1

Conditions

Glioblastoma 19Glioma 14Brain Neoplasms 13Astrocytoma 4Neoplasms 3Meningioma 2Gliosarcoma 2Diffuse Intrinsic Pontine Glioma 2Venous Thromboembolism 1Surgical Wound Infection 1Stroke 1Spinal Diseases 1Spinal Cord Neoplasms 1Seizures 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Osteosarcoma 1Oligodendroglioma 1Neuroma, Acoustic 1Neuroma 1Neurofibromatosis 1 1Neurofibromatoses 1Neuroblastoma 1Neurilemmoma 1Motor Activity 1Melanoma 1Lymphoma, Follicular 1Liver Neoplasms 1Intracranial Hypertension 1Hydrocephalus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Pancreatic Neoplasms × CNS × Clear all
NCT00909558 2010-02-24

Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer

Envita Medical Center, Inc.

Phase 1 Suspended
24 enrolled
BreastCNSGastrointestinalGenitourinary

Breast Neoplasms, Colonic Neoplasms, Glioma, Liver Neoplasms, Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡